<?xml version="1.0" encoding="ASCII"?>
<!DOCTYPE article PUBLIC "-//BEILSTEIN-INSTITUT//DTD Journal Article DTD v0.3 20080808//EN" "http://www.beilstein-journals.org/bjoc/content/xml/journalarticle.dtd">
<article locale="en" publisher="Beilstein-Institut" public-id="1860-5397-4-7" type="full-research-paper" journal="Beilstein Journal of Organic Chemistry" year="2008" volume="4" article="7" issn="1860-5397">
<author first-name="Petri" middle-names="A" last-name="Turhanen" email="Petri.Turhanen@uku.fi" affiliations="a1" corresponding-author="yes"/>
<author first-name="Jouko" middle-names="J" last-name="Veps&#228;l&#228;inen" email="jouko.vepsalainen@uku.fi" affiliations="a1"/>
<affiliation id="a1">University of Kuopio, Department of Biosciences, Laboratory of Chemistry, PO Box 1627, FIN-70211, Kuopio, Finland</affiliation>
<submission-date day="8" month="11" year="2007"/>
<acceptance-date day="21" month="1" year="2008"/>
<publication-date day="21" month="1" year="2008"/>
<title>
<chunk>Unexpected degradation of the bisphosphonate P-C-P bridge under mild conditions</chunk>
</title>
<abstract-section>
<paragraph>
<chunk>Unexpected degradation of the P-C-P bridge from novel bisphosphonate derivative </chunk>
<chunk bold="yes">1a</chunk>
<chunk> and known etidronate trimethyl ester (</chunk>
<chunk bold="yes">1b</chunk>
<chunk>) has been observed under mild reaction conditions. A proposed reaction mechanism for the unexpected degradation of </chunk>
<chunk bold="yes">1a</chunk>
<chunk> and </chunk>
<chunk bold="yes">1b</chunk>
<chunk> is also reported.</chunk>
</paragraph>
</abstract-section>
<abstract-graphic public-id="1860-5397-4-7-graphical-abstract"/>
<external-link type="doi" public-id="10.1186/1860-5397-4-7"/>
<section>
<title>
<chunk>Background</chunk>
</title>
<paragraph>
<chunk>Bisphosphonates (BPs) are analogs of naturally occurring pyrophosphate, where the chemically and enzymatically labile P-O-P bridge has been replaced with a P-C-P bridge, making these compounds relatively resistant to chemical hydrolysis and completely resistant to enzymatic hydrolysis (</chunk>
<link target="f1"/>
<chunk>) </chunk>
<link target="b1"/>
<link target="b2"/>
<link target="b3"/>
<link target="b4"/>
<link target="b5"/>
<chunk>. These BP compounds bind strongly to calcium phosphate and inhibit its formation, aggregation and dissolution </chunk>
<link target="b6"/>
<chunk>. The affinity for the bone mineral represents the basis for their use in the treatment of many diseases associated with increased bone resorption, such as metastatic bone disease, Paget's disease and osteoporosis </chunk>
<link target="b1"/>
<link target="b2"/>
<link target="b3"/>
<link target="b4"/>
<link target="b5"/>
<link target="b6"/>
<chunk>. As described above, the BPs have been used for decades in the therapy of bone diseases but recently these compounds have been found to be active in many other fields, such as in the treatment of parasitic diseases </chunk>
<link target="b7"/>
<link target="b8"/>
<link target="b9"/>
<link target="b10"/>
<link target="b11"/>
<chunk> and atherosclerosis </chunk>
<link target="b12"/>
<chunk>. Furthermore, the BPs have been shown to be effective against calcifying nanoparticles (CNPs, known also as nanobacteria) which may be responsible for several human diseases where calcium phosphate deposition is a hallmark, e.g. cardiovascular diseases, kidney stones, urological diseases, e.g. prostatitis, many cancers and various forms of autoimmune diseases </chunk>
<link target="b13"/>
<link target="b14"/>
<chunk>. Therefore it is very important to understand the chemistry of BPs in detail.</chunk>
</paragraph>
<figure id="f1">
<caption>
<paragraph>
<chunk>Structures of etidronate, pyrophosphate and general structure of bisphosphonates.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-4-7-1"/>
</figure>
<paragraph>
<chunk>Etidronate, (1-hydroxyethylidene)-1,1-bisphosphonic acid (HEBPA) disodium salt, is one of the earliest synthesized and is the most extensively investigated BP compound, still being in clinical use today (</chunk>
<link target="f1"/>
<chunk>) </chunk>
<link target="b1"/>
<link target="b2"/>
<link target="b3"/>
<link target="b4"/>
<link target="b5"/>
<link target="b6"/>
<link target="b15"/>
<chunk>. Our group has designed, synthesized and studied </chunk>
<chunk italic="yes">in vitro</chunk>
<chunk> several different etidronate and alendronate derivatives to act as biodegradable prodrugs of these drugs </chunk>
<link target="b16"/>
<link target="b17"/>
<link target="b18"/>
<link target="b19"/>
<link target="b20"/>
<link target="b21"/>
<link target="b22"/>
<link target="b23"/>
<chunk>. During our ongoing study to prepare new, possibly bioreversible BP derivatives, we observed unexpected degradation of the P-C-P bridge under mild reaction conditions in two of the prepared etidronate derivatives. Earlier, Szymczak et. al. </chunk>
<link target="b24"/>
<chunk> have described the formation of H-phosphonate (also known as phosphite) and phosphate components from a phosphonate-phosphate compound (same kind of structure as </chunk>
<chunk bold="yes">8</chunk>
<chunk> in </chunk>
<link target="s1"/>
<chunk>) either in CH</chunk>
<chunk subscript="yes">3</chunk>
<chunk>CN/Et</chunk>
<chunk subscript="yes">3</chunk>
<chunk>N/H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O (v/v) or phosphate buffer, pH 7.4 at 37 &#176;C. Szajnman et. al. </chunk>
<link target="b25"/>
<chunk> has reported loss of two molecules of phosphite in tetraethyl oxirane-2,2-diylbis(phosphonate); however the kind of degradation which we will discuss in this paper has not been previously reported.</chunk>
</paragraph>
<scheme id="s1">
<caption>
<paragraph>
<chunk>Degradation of trimethyl ester of etidronate (1b) and stability of the tetramethyl ester (</chunk>
<chunk bold="yes">1c</chunk>
<chunk>, R=R`=Me) and P,P`-dimethyl ester (</chunk>
<chunk bold="yes">1d</chunk>
<chunk>, R=Me, R`=Na</chunk>
<chunk superscript="yes">+</chunk>
<chunk>) of etidronate. </chunk>
<chunk italic="yes">Reagents and conditions:</chunk>
<chunk> i) 1 drop of 6 M NaOH, H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O, 1 h, rt, (measured pH was &#8805; 11); ii) 5 equiv triethylamine, H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O, 1 h, 60 &#176;C; iii) when R=R`=Me (</chunk>
<chunk bold="yes">1c</chunk>
<chunk>), 1 eq, triethylamine, H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O, 10 min. ca. 98% conversion. iv) when R=Me, R`=Na</chunk>
<chunk superscript="yes">+</chunk>
<chunk> (</chunk>
<chunk bold="yes">1d</chunk>
<chunk>), 5 equiv NaOH, H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O, overnight, reflux.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-4-7-i2"/>
</scheme>
</section>
<section>
<title>
<chunk>Results and Discussion</chunk>
</title>
<paragraph>
<chunk>As mentioned in the introduction, the P-C-P bridge of BPs has been reported to be relatively stable against chemical hydrolysis, however here we report the unexpectedly easy degradation of two etidronate derivatives into acetate and phosphite moieties. In our ongoing study to prepare novel biodegradable BP derivatives, a new carbonate derivative of etidronate was synthesised. The synthesis was started from the known acetylated etidronic acid </chunk>
<link target="b21"/>
<chunk> (</chunk>
<chunk bold="yes">5</chunk>
<chunk>, see </chunk>
<link target="s2"/>
<chunk>) by treating it with ethyl chloroformate and sodium carbonate. The NMR spectroscopy results were surprising since they pointed to the formation of a novel etidronate derivative </chunk>
<chunk bold="yes">1a</chunk>
<chunk> (see </chunk>
<link target="s2"/>
<chunk>). In the </chunk>
<chunk superscript="yes">31</chunk>
<chunk>P NMR spectrum, there were four doublets (1:1:1:1) due to the presence of two diastereomers. The </chunk>
<chunk superscript="yes">1</chunk>
<chunk>H NMR spectrum contained two complicated splitting patterns at approx. 4.46 and 4.28 ppm, their integral ratio was 1 to 3, respectively, indicating two different kinds of -OCH</chunk>
<chunk subscript="yes">2</chunk>
<chunk> groups in ratio 1:3. After inspection of </chunk>
<chunk superscript="yes">13</chunk>
<chunk>C NMR spectra and the ESI-MS results, we concluded that the prepared molecule had the unanticipated structure of </chunk>
<chunk bold="yes">1a</chunk>
<chunk> and not the expected structure where R</chunk>
<chunk superscript="yes">2</chunk>
<chunk>=R</chunk>
<chunk superscript="yes">3</chunk>
<chunk>=C(O)OEt (see </chunk>
<link target="s2"/>
<chunk>). To confirm the selective formation of </chunk>
<chunk bold="yes">1a</chunk>
<chunk>, the synthesis was repeated several times, but the result was always the same (formation of </chunk>
<chunk bold="yes">1a</chunk>
<chunk> was observed in all experiments), though in some experiments a transesterification of the acetyl group to C(O)OEt group was observed in yields of 0&#8211;13% as confirmed by the </chunk>
<chunk superscript="yes">1</chunk>
<chunk>H and </chunk>
<chunk superscript="yes">31</chunk>
<chunk>P NMR spectra. We were unable to provide any direct explanation for the variation in the transesterification proportion. Etidronic acid was also tested as a starting material to prepare a derivative such as </chunk>
<chunk bold="yes">1a</chunk>
<chunk> [C(O)OEt group instead of Ac group], but the reaction did not occur under the same conditions as those used in the preparation of </chunk>
<chunk bold="yes">1a</chunk>
<chunk>. Our subsequent studies with derivative </chunk>
<chunk bold="yes">1a</chunk>
<chunk> led us to another very surprising result, which occurred when 4 equiv of NaOH (40% NaOH in H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O) were added to the solution of </chunk>
<chunk bold="yes">1a</chunk>
<chunk> in MeOH and stirred for 30 minutes at room temperature. After evaporation of the reaction mixture to dryness, the residue contained almost exclusively (&gt;95% degradation was observed) sodium acetate </chunk>
<chunk bold="yes">6</chunk>
<chunk> and phosphites </chunk>
<chunk bold="yes">2</chunk>
<chunk>&#8211;</chunk>
<chunk bold="yes">4</chunk>
<chunk> (compound </chunk>
<chunk bold="yes">4</chunk>
<chunk> can be also called phosphorous acid monosodium salt) as can be seen in </chunk>
<link target="s2"/>
<chunk>. Compounds </chunk>
<chunk bold="yes">2</chunk>
<chunk>&#8211;</chunk>
<chunk bold="yes">4</chunk>
<chunk> were readily characterized by their P-H chemical shifts and characteristic </chunk>
<chunk superscript="yes">1</chunk>
<chunk>J</chunk>
<chunk subscript="yes">HP</chunk>
<chunk> coupling constants (ca. 600 Hz). In the </chunk>
<chunk superscript="yes">31</chunk>
<chunk>P NMR spectrum, there were three different monophosphorus components confirmed to be compounds </chunk>
<chunk bold="yes">2</chunk>
<chunk>&#8211;</chunk>
<chunk bold="yes">4</chunk>
<chunk>. Two moles of acetate 6 were detected compared to one mole of the total amount of phosphites </chunk>
<chunk bold="yes">2</chunk>
<chunk>&#8211;</chunk>
<chunk bold="yes">4</chunk>
<chunk> which was the expected result. Interestingly, the decomposition mixture of </chunk>
<chunk bold="yes">1a</chunk>
<chunk> contained not only monoethyl phosphite </chunk>
<chunk bold="yes">2</chunk>
<chunk> and phosphite </chunk>
<chunk bold="yes">4</chunk>
<chunk> but also monomethyl derivative </chunk>
<chunk bold="yes">3</chunk>
<chunk> (according the </chunk>
<chunk superscript="yes">31</chunk>
<chunk>P NMR spectrum, the ratio was approx.: 1:0.86:1, respectively, see </chunk>
<link target="si1"/>
<chunk>, S13). The formation of this monomethyl phosphite </chunk>
<chunk bold="yes">3</chunk>
<chunk> under the conditions used (see </chunk>
<link target="s2"/>
<chunk>, procedure ii) can be explained based on: 1) partial transesterification of bisphosphonate </chunk>
<chunk bold="yes">1a</chunk>
<chunk> before degradation of P-C-P bridge, 2) partial esterification of phosphonate group after the carbonate groups (R</chunk>
<chunk superscript="yes">3</chunk>
<chunk>) decomposition from compound </chunk>
<chunk bold="yes">1a</chunk>
<chunk> (this is proposed to occur rapidly after the addition of 40% NaOH) and before the degradation of P-C-P bridge, 3) partial transesterification of </chunk>
<chunk bold="yes">2</chunk>
<chunk>, and 4) esterification of </chunk>
<chunk bold="yes">4</chunk>
<chunk> (see </chunk>
<link target="s2"/>
<chunk>).</chunk>
</paragraph>
<scheme id="s2">
<caption>
<paragraph>
<chunk>Preparation of BP derivative </chunk>
<chunk bold="yes">1a</chunk>
<chunk> (R</chunk>
<chunk superscript="yes">2</chunk>
<chunk> = Et, R</chunk>
<chunk superscript="yes">3</chunk>
<chunk> = C(O)OEt) and its degradation to acetate </chunk>
<chunk bold="yes">6</chunk>
<chunk> and phosphites </chunk>
<chunk bold="yes">2</chunk>
<chunk>&#8211;</chunk>
<chunk bold="yes">4</chunk>
<chunk>. </chunk>
<chunk italic="yes">Reagents and conditions:</chunk>
<chunk> i) excess ClC(O)OEt, 6 equiv Na</chunk>
<chunk subscript="yes">2</chunk>
<chunk>CO</chunk>
<chunk subscript="yes">3</chunk>
<chunk>, reflux, overnight, 55%; ii) 4 equiv NaOH (40% NaOH in H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O), MeOH, 30 min, rt.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-4-7-i1"/>
</scheme>
<paragraph>
<chunk>These unexpected degradation results we observed for the HEBPA derivative </chunk>
<chunk bold="yes">1a</chunk>
<chunk> led us to examine what would happen to more simple derivatives of HEBPA, such as trimethyl (</chunk>
<chunk bold="yes">1b</chunk>
<chunk>), tetramethyl (</chunk>
<chunk bold="yes">1c</chunk>
<chunk>) and P,P`-dimethyl (</chunk>
<chunk bold="yes">1d</chunk>
<chunk>) esters of etidronate under the same kinds of conditions (see </chunk>
<link target="s1"/>
<chunk>). Compounds </chunk>
<chunk bold="yes">1b</chunk>
<chunk>&#8211;</chunk>
<chunk bold="yes">d</chunk>
<chunk> were prepared as reported elsewhere </chunk>
<link target="b20"/>
<link target="b26"/>
<link target="b27"/>
<link target="b28"/>
<chunk>. Again very surprising results were obtained. Trimethyl ester of etidronate (</chunk>
<chunk bold="yes">1b</chunk>
<chunk>) was degraded to the acetate </chunk>
<chunk bold="yes">6</chunk>
<chunk> and phosphorous acid salt </chunk>
<chunk bold="yes">4</chunk>
<chunk>, under even milder conditions than the degradation of </chunk>
<chunk bold="yes">1a</chunk>
<chunk> (50 mg of </chunk>
<chunk bold="yes">1b</chunk>
<chunk> in 1 ml H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O and 1 drop of 6 M NaOH was stirred for 1 hour at rt; measured pH was &#8805; 11; see </chunk>
<link target="s1"/>
<chunk>). Tetramethyl (</chunk>
<chunk bold="yes">1c</chunk>
<chunk>) or P,P`-dimethyl ester were not degraded under the same conditions, only the formation of phosphonate-phosphate derivative </chunk>
<chunk bold="yes">8</chunk>
<chunk> from </chunk>
<chunk bold="yes">1c</chunk>
<chunk> was observed as expected in the light of the earlier results concern the rearrangement process </chunk>
<link target="b17"/>
<link target="b20"/>
<link target="b21"/>
<link target="b29"/>
<link target="b30"/>
<link target="b31"/>
<link target="b32"/>
<chunk>. This rearrangement of </chunk>
<chunk bold="yes">1c</chunk>
<chunk> to </chunk>
<chunk bold="yes">8</chunk>
<chunk> was observed to happen rapidly and almost completely (98% conversion) when 1 equiv of triethylamine was present in water (see </chunk>
<link target="s1"/>
<chunk>).</chunk>
</paragraph>
<paragraph>
<chunk>Compound </chunk>
<chunk bold="yes">1b</chunk>
<chunk> was selectively degraded to the phosphite </chunk>
<chunk bold="yes">3</chunk>
<chunk> and acetyl phosphonate </chunk>
<chunk bold="yes">7</chunk>
<chunk> when </chunk>
<chunk bold="yes">5</chunk>
<chunk> equiv of triethylamine was used in H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O (see </chunk>
<link target="s1"/>
<chunk>). Dialkyl acetylphosphonates and dialkyl phosphites are common starting materials for the synthesis of tetraalkyl esters of HEBPA </chunk>
<link target="b26"/>
<link target="b27"/>
<chunk>, but this is the first time when the &#8220;reverse&#8221; synthesis has been reported. P,P`-dimethyl ester </chunk>
<chunk bold="yes">1d</chunk>
<chunk> did not degrade to compounds </chunk>
<chunk bold="yes">3</chunk>
<chunk> and </chunk>
<chunk bold="yes">7</chunk>
<chunk> or </chunk>
<chunk bold="yes">6</chunk>
<chunk> and </chunk>
<chunk bold="yes">4</chunk>
<chunk> even when refluxed overnight with 5 equiv NaOH in H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O.</chunk>
</paragraph>
<paragraph>
<chunk>The decomposition mechanism for </chunk>
<chunk bold="yes">1b</chunk>
<chunk> can be explained in two ways; either via a decomposition mechanism resembling the reversible route of the formation of tetraesters (see </chunk>
<link target="s3"/>
<chunk> route </chunk>
<chunk bold="yes">a</chunk>
<chunk>), since e.g., </chunk>
<chunk bold="yes">1c</chunk>
<chunk>, are prepared from phosphites, H-P(O)(OMe)</chunk>
<chunk subscript="yes">2</chunk>
<chunk>, and phosphonates, MeCOP(O)(OMe)</chunk>
<chunk subscript="yes">2</chunk>
<chunk>, or route </chunk>
<chunk bold="yes">b</chunk>
<chunk> resembling the rearrangement process </chunk>
<link target="b19"/>
<chunk>. The driving force in both reactions is the formation of three charged molecules from one P-C-P compound since this is a highly entropically favoured process. Decomposition of the first P-C bond starts with deprotonation of the hydroxyl group followed by elimination of the methyl phosphite and the formation of ketone (route </chunk>
<chunk bold="yes">a</chunk>
<chunk>) or by nucleophilic attack of the oxygen of the ionized phosphate on the bridging carbon to release dimethyl phosphite and the oxirane ring containing derivative (route </chunk>
<chunk bold="yes">b</chunk>
<chunk>). In route </chunk>
<chunk bold="yes">a</chunk>
<chunk>, water or hydroxide ion attacks the carbonyl carbon and P-C bond cleavage occurs giving rise to acetic acid and dimethyl phosphite which can undergo a further reaction with water or hydroxide to give methyl phosphite. In route </chunk>
<chunk bold="yes">b</chunk>
<chunk>, the attack of water on the carbon of oxirane ring yields hydrate followed by elimination of methyl phosphite and acetic acid. We believe that route </chunk>
<chunk bold="yes">a</chunk>
<chunk> is more probable, since during the reaction with a weaker base, such as triethylamine, only the first P-C bond is cleaved and products </chunk>
<chunk bold="yes">3</chunk>
<chunk> and </chunk>
<chunk bold="yes">7</chunk>
<chunk> are observed. On the other hand, decomposition of </chunk>
<chunk bold="yes">1a</chunk>
<chunk> is more likely to follow route </chunk>
<chunk bold="yes">b</chunk>
<chunk>.</chunk>
</paragraph>
<scheme id="s3">
<caption>
<paragraph>
<chunk>Proposed reaction mechanism for </chunk>
<chunk bold="yes">1b</chunk>
<chunk> decomposition.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-4-7-i3"/>
</scheme>
<paragraph>
<chunk>The proposed decomposition mechanism for </chunk>
<chunk bold="yes">1a</chunk>
<chunk> (see </chunk>
<link target="s4"/>
<chunk>) is more complicated. The reaction starts with the hydrolysis of one carbonate ester leading to a monoanion comparable to </chunk>
<chunk bold="yes">1b</chunk>
<chunk>. After this step, the decomposition can continue following routes that are similar to either route </chunk>
<chunk bold="yes">a</chunk>
<chunk> or route </chunk>
<chunk bold="yes">b</chunk>
<chunk> in </chunk>
<link target="s3"/>
<chunk>. The other possibility, route </chunk>
<chunk bold="yes">b</chunk>
<chunk> (in </chunk>
<link target="s4"/>
<chunk>), is a nucleophilic attack of oxygen to the bridging carbon and the formation of an oxirane ring containing derivative, since the adjacent acetate group is a rather good leaving group. Subsequently, P-C-bond decomposition will follow the same mechanism as reported in </chunk>
<link target="s3"/>
<chunk>.</chunk>
</paragraph>
<scheme id="s4">
<caption>
<paragraph>
<chunk>Proposed reaction mechanism for </chunk>
<chunk bold="yes">1a</chunk>
<chunk> decomposition.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-4-7-i4"/>
</scheme>
<paragraph>
<chunk>The initial reaction in </chunk>
<link target="s3"/>
<chunk> also explains the formation of rearranged product </chunk>
<chunk bold="yes">8</chunk>
<chunk> from tetraester </chunk>
<chunk bold="yes">1c</chunk>
<chunk> (this rearrangement is proposed to happen via oxirane ring) </chunk>
<link target="b19"/>
<chunk>, since the charged oxygen is a good nucleophile compared to OH-group and far better than oxygen bound to phosphorus with a double bond (P=O).</chunk>
</paragraph>
<paragraph>
<chunk>All of the compounds were easily identified by their </chunk>
<chunk superscript="yes">1</chunk>
<chunk>H, </chunk>
<chunk superscript="yes">13</chunk>
<chunk>C and </chunk>
<chunk superscript="yes">31</chunk>
<chunk>P NMR spectra. In </chunk>
<chunk superscript="yes">31</chunk>
<chunk>P NMR signals for the phosphites </chunk>
<chunk bold="yes">2</chunk>
<chunk>, </chunk>
<chunk bold="yes">3</chunk>
<chunk> and </chunk>
<chunk bold="yes">4</chunk>
<chunk> were 6.26 ppm, 8.47 ppm and 5.81 ppm, respectively and 0.10 ppm for acetylphosphonate </chunk>
<chunk bold="yes">7</chunk>
<chunk>. These values were comparable to those reported earlier </chunk>
<link target="b27"/>
<chunk>.</chunk>
</paragraph>
</section>
<section>
<title>
<chunk>Conclusion</chunk>
</title>
<paragraph>
<chunk>In conclusion, a novel carbonate derivative of etidronate (</chunk>
<chunk bold="yes">1a</chunk>
<chunk>) was prepared by the reaction of acetylated etidronic acid with ethyl chloroformate and sodium carbonate. Compound </chunk>
<chunk bold="yes">1a</chunk>
<chunk> was found to undergo remarkably facile cleavage of the P-C bond under mild basic conditions. The trimethyl ester of etidronate (</chunk>
<chunk bold="yes">1b</chunk>
<chunk>) was also found to undergo readily P-C bond cleavage under similar conditions. The trimethyl ester of etidronate (</chunk>
<chunk bold="yes">1b</chunk>
<chunk>) was also observed to be degraded to phosphite </chunk>
<chunk bold="yes">3</chunk>
<chunk> and acetylphosphonate </chunk>
<chunk bold="yes">7</chunk>
<chunk> when mixed in H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O containing 5 equiv of triethylamine. Some mechanisms to explain these behaviors have been proposed though further investigations will be necessary to confirm the proposed degradation pathways.</chunk>
</paragraph>
</section>
<supporting-information>
<supporting-information-file id="si1" public-id="1860-5397-4-7-S1">
<caption>
<paragraph>
<chunk>Unexpected degradation of bisphosphonate P-C-P bridge under mild conditions. Experimental procedures, full spectroscopic data and NMR spectra for the novel compound </chunk>
<chunk bold="yes">1a</chunk>
<chunk> and NMR spectra for the degradation studies of </chunk>
<chunk bold="yes">1a</chunk>
<chunk> and </chunk>
<chunk bold="yes">1b</chunk>
<chunk>.</chunk>
</paragraph>
</caption>
</supporting-information-file>
</supporting-information>
<acknowledgements>
<paragraph>
<chunk>Authors would like to thank Mrs. Maritta Salminkoski for her expert technical assistance for performing most of the experiments reported here, and Mrs. Katja H&#246;ppi for the ESI-MS analysis.</chunk>
</paragraph>
</acknowledgements>
<reference id="b1" type="book" publisher-name="The Parthenon Publishing Group Inc." publisher-location="New York">
<reference-author first-name="H" last-name="Fleisch"/>
<source>
<chunk>Bisphosphonates in Bone Disease: From the Laboratory to the Patient</chunk>
</source>
<publication-date year="1995"/>
</reference>
<reference id="b2" type="article" volume="13" volume-supplement="1" first-page="S41" last-page="S49">
<reference-author first-name="S" middle-names="E" last-name="Papapoulos"/>
<reference-author first-name="J" middle-names="O" last-name="Landman"/>
<reference-author first-name="O" middle-names="L M" last-name="Bijvoet"/>
<reference-author first-name="C" middle-names="W G M" last-name="L&#246;wik"/>
<reference-author first-name="R" last-name="Valkema"/>
<reference-author first-name="E" middle-names="K J" last-name="Pauwels"/>
<reference-author first-name="P" last-name="Vermeij"/>
<source>
<chunk>Bone</chunk>
</source>
<publication-date year="1992"/>
</reference>
<reference id="b3" type="article" volume="3" first-page="69" last-page="78">
<reference-author first-name="A" middle-names="J" last-name="Yates"/>
<reference-author first-name="G" middle-names="A" last-name="Rodan"/>
<source>
<chunk>Drug Discovery Today</chunk>
</source>
<publication-date year="1998"/>
<external-link type="doi" public-id="10.1016/S1359-6446(97)01134-3"/>
</reference>
<reference id="b4" type="article" volume="95" volume-supplement="1" issue="5" first-page="S48" last-page="S52">
<reference-author first-name="S" middle-names="E" last-name="Papapoulos"/>
<source>
<chunk>Am. J. Med.</chunk>
</source>
<publication-date year="1993"/>
<external-link type="doi" public-id="10.1016/0002-9343(93)90383-Z"/>
</reference>
<reference id="b5" type="article" volume="88" first-page="431" last-page="436">
<reference-author first-name="S" last-name="Giannini"/>
<reference-author first-name="A" last-name="D'Angelo"/>
<reference-author first-name="L" last-name="Sartori"/>
<reference-author first-name="G" last-name="Passeri"/>
<reference-author first-name="L" last-name="Dalle Carbonare"/>
<reference-author first-name="G" last-name="Crepaldi"/>
<source>
<chunk>Obstet. Gynecol.</chunk>
</source>
<publication-date year="1996"/>
<external-link type="doi" public-id="10.1016/0029-7844(96)00171-8"/>
</reference>
<reference id="b6" type="article" volume="42" first-page="919" last-page="944">
<reference-author first-name="H" last-name="Fleisch"/>
<source>
<chunk>Drugs</chunk>
</source>
<publication-date year="1991"/>
</reference>
<reference id="b7" type="article" volume="13" first-page="3231" last-page="3235">
<reference-author first-name="S" middle-names="H" last-name="Szajnman"/>
<reference-author first-name="A" last-name="Montalvetti"/>
<reference-author first-name="Y" last-name="Wang"/>
<reference-author first-name="R" last-name="Docampo"/>
<reference-author first-name="J" middle-names="B" last-name="Rodriguez"/>
<source>
<chunk>Bioorg. Med. Chem. Lett.</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.1016/S0960-894X(03)00663-2"/>
</reference>
<reference id="b8" type="article" volume="11" first-page="789" last-page="792">
<reference-author first-name="S" middle-names="H" last-name="Szajnman"/>
<reference-author first-name="B" middle-names="N" last-name="Bailey"/>
<reference-author first-name="R" last-name="Docampo"/>
<reference-author first-name="J" middle-names="B" last-name="Rodriguez"/>
<source>
<chunk>Bioorg. Med. Chem. Lett.</chunk>
</source>
<publication-date year="2001"/>
<external-link type="doi" public-id="10.1016/S0960-894X(01)00057-9"/>
</reference>
<reference id="b9" type="article" volume="45" first-page="2904" last-page="2914">
<reference-author first-name="M" middle-names="B" last-name="Martin"/>
<reference-author first-name="J" middle-names="M" last-name="Sanders"/>
<reference-author first-name="H" last-name="Kendrick"/>
<reference-author first-name="K" last-name="de Luca-Fradley"/>
<reference-author first-name="J" middle-names="C" last-name="Lewis"/>
<reference-author first-name="J" middle-names="S" last-name="Grimley"/>
<reference-author first-name="E" middle-names="M" last-name="Van Brussel"/>
<reference-author first-name="J" middle-names="R" last-name="Olsen"/>
<reference-author first-name="G" middle-names="A" last-name="Meints"/>
<reference-author first-name="A" last-name="Burzynska"/>
<reference-author first-name="P" last-name="Kafarski"/>
<reference-author first-name="S" middle-names="L" last-name="Croft"/>
<reference-author first-name="E" last-name="Oldfield"/>
<source>
<chunk>J. Med. Chem.</chunk>
</source>
<publication-date year="2002"/>
<external-link type="doi" public-id="10.1021/jm0102809"/>
</reference>
<reference id="b10" type="article" volume="23" first-page="273" last-page="285">
<reference-author first-name="L" middle-names="R" last-name="Garzoni"/>
<reference-author first-name="A" last-name="Caldera"/>
<reference-author first-name="M" last-name="Nazareth L. Meirelles"/>
<reference-author first-name="S" middle-names="L" last-name="Castro"/>
<reference-author first-name="R" last-name="Docampo"/>
<reference-author first-name="G" middle-names="A" last-name="Meints"/>
<reference-author first-name="E" last-name="Oldfield"/>
<reference-author first-name="J" middle-names="A" last-name="Urbina"/>
<source>
<chunk>Int. J. Antimicrob. Agents</chunk>
</source>
<publication-date year="2004"/>
<external-link type="doi" public-id="10.1016/j.ijantimicag.2003.07.020"/>
</reference>
<reference id="b11" type="article" volume="23" first-page="286" last-page="290">
<reference-author first-name="L" middle-names="R" last-name="Garzoni"/>
<reference-author first-name="M" middle-names="C" last-name="Waghabi"/>
<reference-author first-name="M" middle-names="M" last-name="Baptista"/>
<reference-author first-name="S" middle-names="L" last-name="Castro"/>
<reference-author first-name="M" last-name="Nazareth L. Meirelles"/>
<reference-author first-name="C" middle-names="C" last-name="Britto"/>
<reference-author first-name="R" last-name="Docampo"/>
<reference-author first-name="E" last-name="Oldfield"/>
<reference-author first-name="J" middle-names="A" last-name="Urbina"/>
<source>
<chunk>Int. J. Antimicrob. Agents</chunk>
</source>
<publication-date year="2004"/>
<external-link type="doi" public-id="10.1016/j.ijantimicag.2003.07.019"/>
</reference>
<reference id="b12" type="article" volume="35" first-page="287" last-page="296">
<reference-author first-name="R" last-name="Ylitalo"/>
<source>
<chunk>Gen. Pharmacol.</chunk>
</source>
<publication-date year="2000"/>
<external-link type="doi" public-id="10.1016/S0306-3623(01)00121-5"/>
</reference>
<reference id="b13" type="article" volume="42" first-page="549" last-page="552">
<reference-author first-name="E" middle-names="O" last-name="Kajander"/>
<source>
<chunk>Lett. Appl. Microbiol.</chunk>
</source>
<publication-date year="2006"/>
<external-link type="doi" public-id="10.1111/j.1472-765X.2006.01945.x"/>
</reference>
<reference id="b14" type="note">
<comment>
<chunk>Aho, K.; Soininen, T.; Turhanen, P. A.; Kajander, E. O.; Veps&#228;l&#228;inen, J. J. Unpublished results</chunk>
</comment>
</reference>
<reference id="b15" type="article" volume="88" first-page="6" last-page="14">
<reference-author first-name="P" middle-names="P" last-name="Major"/>
<reference-author first-name="A" last-name="Lipton"/>
<reference-author first-name="J" last-name="Berenson"/>
<reference-author first-name="G" last-name="Hortobagyi"/>
<source>
<chunk>Cancer (N. Y.)</chunk>
</source>
<publication-date year="2000"/>
<external-link type="doi" public-id="10.1002/(SICI)1097-0142(20000101)88:1&#60;6::AID-CNCR3&#62;3.0.CO;2-D"/>
</reference>
<reference id="b16" type="article" volume="1" first-page="3223" last-page="3226">
<reference-author first-name="P" middle-names="A" last-name="Turhanen"/>
<reference-author first-name="R" last-name="Niemi"/>
<reference-author first-name="M" last-name="Per&#228;kyl&#228;"/>
<reference-author first-name="T" last-name="J&#228;rvinen"/>
<reference-author first-name="J" middle-names="J" last-name="Veps&#228;l&#228;inen"/>
<source>
<chunk>Org. Biomol. Chem.</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.1039/b305979k"/>
</reference>
<reference id="b17" type="article" first-page="2119" last-page="2121">
<reference-author first-name="P" middle-names="A" last-name="Turhanen"/>
<reference-author first-name="J" middle-names="J" last-name="Veps&#228;l&#228;inen"/>
<source>
<chunk>Synthesis</chunk>
</source>
<publication-date year="2005"/>
<external-link type="doi" public-id="10.1055/s-2005-869984"/>
</reference>
<reference id="b18" type="article" first-page="3063" last-page="3066">
<reference-author first-name="P" middle-names="A" last-name="Turhanen"/>
<reference-author first-name="J" middle-names="J" last-name="Veps&#228;l&#228;inen"/>
<source>
<chunk>Synthesis</chunk>
</source>
<publication-date year="2005"/>
<external-link type="doi" public-id="10.1055/s-2005-916032"/>
</reference>
<reference id="b19" type="article" volume="11" first-page="173" last-page="180">
<reference-author first-name="R" last-name="Niemi"/>
<reference-author first-name="P" last-name="Turhanen"/>
<reference-author first-name="J" last-name="Veps&#228;l&#228;inen"/>
<reference-author first-name="H" last-name="Taipale"/>
<reference-author first-name="T" last-name="J&#228;rvinen"/>
<source>
<chunk>Eur. J. Pharm. Sci.</chunk>
</source>
<publication-date year="2000"/>
<external-link type="doi" public-id="10.1016/S0928-0987(00)00099-3"/>
</reference>
<reference id="b20" type="article" first-page="633" last-page="637">
<reference-author first-name="P" middle-names="A" last-name="Turhanen"/>
<reference-author first-name="M" middle-names="J" last-name="Ahlgren"/>
<reference-author first-name="T" last-name="J&#228;rvinen"/>
<reference-author first-name="J" middle-names="J" last-name="Veps&#228;l&#228;inen"/>
<source>
<chunk>Synthesis</chunk>
</source>
<publication-date year="2001"/>
<external-link type="doi" public-id="10.1055/s-2001-12353"/>
</reference>
<reference id="b21" type="article" first-page="992" last-page="994">
<reference-author first-name="P" middle-names="A" last-name="Turhanen"/>
<reference-author first-name="J" middle-names="J" last-name="Veps&#228;l&#228;inen"/>
<source>
<chunk>Synthesis</chunk>
</source>
<publication-date year="2004"/>
<external-link type="doi" public-id="10.1055/s-2004-822345"/>
</reference>
<reference id="b22" type="article" volume="2" article-number="2">
<reference-author first-name="P" middle-names="A" last-name="Turhanen"/>
<reference-author first-name="J" middle-names="J" last-name="Veps&#228;l&#228;inen"/>
<source>
<chunk>Beilstein J. Org. Chem.</chunk>
</source>
<publication-date year="2006"/>
<external-link type="doi" public-id="10.1186/1860-5397-2-2"/>
</reference>
<reference id="b23" type="article" volume="9" first-page="1201" last-page="1208">
<reference-author first-name="J" middle-names="J" last-name="Veps&#228;l&#228;inen"/>
<source>
<chunk>Curr. Med. Chem.</chunk>
</source>
<publication-date year="2002"/>
</reference>
<reference id="b24" type="article" volume="5" first-page="3571" last-page="3573">
<reference-author first-name="M" last-name="Szymczak"/>
<reference-author first-name="A" last-name="Szyma&#324;ska"/>
<reference-author first-name="J" last-name="Stawi&#324;ski"/>
<reference-author first-name="J" last-name="Boryski"/>
<reference-author first-name="A" last-name="Kraszewski"/>
<source>
<chunk>Org. Lett.</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.1021/ol035166u"/>
</reference>
<reference id="b25" type="article" first-page="3687" last-page="3696">
<reference-author first-name="S" middle-names="H" last-name="Szajnman"/>
<reference-author first-name="G" last-name="Garc&#237;a Li&#241;ares"/>
<reference-author first-name="P" last-name="Moro"/>
<reference-author first-name="J" middle-names="B" last-name="Rodriguez"/>
<source>
<chunk>Eur. J. Org. Chem.</chunk>
</source>
<publication-date year="2005"/>
<external-link type="doi" public-id="10.1002/ejoc.200500097"/>
</reference>
<reference id="b26" type="article" volume="36" first-page="3843" last-page="3845">
<reference-author first-name="D" middle-names="A" last-name="Nicholson"/>
<reference-author first-name="H" last-name="Vaughn"/>
<source>
<chunk>J. Org. Chem.</chunk>
</source>
<publication-date year="1971"/>
<external-link type="doi" public-id="10.1021/jo00823a621"/>
</reference>
<reference id="b27" type="article" volume="170" first-page="115" last-page="133">
<reference-author first-name="P" middle-names="A" last-name="Turhanen"/>
<reference-author first-name="M" middle-names="J" last-name="Ahlgren"/>
<reference-author first-name="T" last-name="J&#228;rvinen"/>
<reference-author first-name="J" middle-names="J" last-name="Veps&#228;l&#228;inen"/>
<source>
<chunk>Phosphorus, Sulfur Silicon Relat. Elem.</chunk>
</source>
<publication-date year="2001"/>
<external-link type="doi" public-id="10.1080/10426500108040589"/>
</reference>
<reference id="b28" type="article" volume="16" first-page="511" last-page="520">
<reference-author first-name="J" middle-names="M" last-name="Van Gelder"/>
<reference-author first-name="E" last-name="Breuer"/>
<reference-author first-name="A" last-name="Ornoy"/>
<reference-author first-name="A" last-name="Schlossman"/>
<reference-author first-name="N" last-name="Patlas"/>
<reference-author first-name="G" last-name="Golomb"/>
<source>
<chunk>Bone</chunk>
</source>
<publication-date year="1995"/>
<external-link type="doi" public-id="10.1016/8756-3282(95)00081-N"/>
</reference>
<reference id="b29" type="article" volume="49" first-page="3060" last-page="3063">
<reference-author first-name="P" last-name="Vachal"/>
<reference-author first-name="J" middle-names="J" last-name="Hale"/>
<reference-author first-name="Z" last-name="Lu"/>
<reference-author first-name="E" middle-names="C" last-name="Streckfuss"/>
<reference-author first-name="S" middle-names="G" last-name="Mills"/>
<reference-author first-name="M" last-name="MacCoss"/>
<reference-author first-name="D" middle-names="H" last-name="Yin"/>
<reference-author first-name="K" last-name="Algayer"/>
<reference-author first-name="K" last-name="Manser"/>
<reference-author first-name="F" last-name="Kesisoglou"/>
<reference-author first-name="S" last-name="Ghosh"/>
<reference-author first-name="L" middle-names="L" last-name="Alani"/>
<source>
<chunk>J. Med. Chem.</chunk>
</source>
<publication-date year="2006"/>
<external-link type="doi" public-id="10.1021/jm060398v"/>
</reference>
<reference id="b30" type="article" volume="84" first-page="1876" last-page="1879">
<reference-author first-name="S" middle-names="J" last-name="Fitch"/>
<reference-author first-name="K" last-name="Moedritzer"/>
<source>
<chunk>J. Am. Chem. Soc.</chunk>
</source>
<publication-date year="1962"/>
<external-link type="doi" public-id="10.1021/ja00869a022"/>
</reference>
<reference id="b31" type="article" volume="60" first-page="5209" last-page="5213">
<reference-author first-name="R" last-name="Ruel"/>
<reference-author first-name="J-P" last-name="Bouvier"/>
<reference-author first-name="R" middle-names="N" last-name="Young"/>
<source>
<chunk>J. Org. Chem.</chunk>
</source>
<publication-date year="1995"/>
<external-link type="doi" public-id="10.1021/jo00121a044"/>
</reference>
<reference id="b32" type="article" volume="27" first-page="301" last-page="312">
<reference-author first-name="A" last-name="Tromelin"/>
<reference-author first-name="D" last-name="El Manouni"/>
<reference-author first-name="R" last-name="Burgada"/>
<source>
<chunk>Phosphorus Sulfur Relat. Elem.</chunk>
</source>
<publication-date year="1986"/>
<external-link type="doi" public-id="10.1080/03086648608072784"/>
</reference>
<copyright year="2008" holder="Turhanen and Veps&#228;l&#228;inen; licensee Beilstein-Institut." link="http://creativecommons.org/licenses/by/2.0">
<paragraph>
<chunk>This is an Open Access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</chunk>
</paragraph>
<paragraph>
<chunk>The license is subject to the </chunk>
<chunk italic="yes">Beilstein Journal of Organic Chemistry</chunk>
<chunk> terms and conditions: (http://www.beilstein-journals.org/bjoc)</chunk>
</paragraph>
</copyright>
</article>
